Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.4) replacing the previous v3.5.3, indicating an updated software release.
    Difference
    0.0%
    Check dated 2026-05-15T04:59:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The sponsor designation in the study details was updated from Verona Pharma plc to Verona Pharma, Inc., a subsidiary of Merck & Co., Inc., Rahway, NJ, signaling a change in the corporate structure and sponsor organization used for the trial.
    Difference
    0.1%
    Check dated 2026-05-08T00:26:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing v3.5.2, indicating an updated page version rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-04-30T18:10:45.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    No changes were detected in the provided additions/deletions inputs.
    Difference
    0.0%
    Check dated 2026-04-23T15:26:22.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:52:25.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    IQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed.
    Difference
    0.0%
    Check dated 2026-04-09T09:18:53.000Z thumbnail image

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.